Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery

NovartisAlcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to streamline, simplify and improve cataract surgery for surgeons and patients.

The SMART Suite by Alcon will connect multiple diagnostic and surgical devices through a digital, open cloud-based infrastructure that seamlessly integrates with practices' existing cataract diagnostic equipment, electronic medical record (EMR) systems, and technologies in the Alcon Cataract Refractive Suite. As envisioned, eye care professionals will have easy access to patients' vital diagnostic data throughout the cataract procedure, providing a simplified clinical process, consistency and greater efficiency. The cloud-based data will help eye care professionals analyze and optimize procedures with increased precision, driving improved patient outcomes.

"The SMART Suite by Alcon will be an important addition to our market-leading cataract refractive equipment portfolio and it builds on our existing cloud-based technologies like the ORA System," said Michael Onuscheck, President, Global Business & Innovation at Alcon. "Our collaboration with Philips reflects our ongoing commitment to deliver market-leading innovations that improve the surgical process and deliver optimal outcomes for patients."

The SMART Suite by Alcon will be built on the Philips HealthSuite digital platform, which provides the proven expertise and regulatory compliance for cloud-based services and technical tools that will enable SMART Suite to fit seamlessly into customers' practices. HealthSuite's medical cloud capabilities will connect Alcon and third party surgical and diagnostic devices, while its data aggregation and storage services will allow eye care professionals to collect data from devices, EMRs and patients and store it securely. The identity and access management capabilities are designed to safeguard the privacy of health data by controlling administrator, as well as patient and clinician access to data. In addition, the Philips platform will enable the SMART Suite by Alcon to facilitate secure, open data exchange between facilities, clinicians and patients.

"We are excited to facilitate the global shift of eye care professionals and the eye care industry to connected health," said Dale Wiggins, Business Leader HealthSuite digital platform at Philips. "The ability of Philips' HealthSuite digital platform to securely unify and connect devices and data while providing advanced analytics capabilities is a powerful tool for the next generation of personalized eye care solutions."

Alcon plans to announce additional details on the SMART Suite in mid-2019. The SMART Suite will be fully compatible with currently available surgical equipment, including Centurion, ORA, Verion, LenSx and other planned future additions to the Alcon Cataract Refractive Suite.

About Alcon

Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our products touch the lives of more than 260 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care.

About Novartis

Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...